Pharmarise Holdings (2796) · FactRestated
Change in Full-Time Corporate Auditors
First written in FY2024-Q3. 1 of 2 entries say "Restated". Latest entry: FY2024.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Changes in Corporate Auditors and Transition to a Company with an Audit and Supervisory CommitteeA theme 44 companies write about · 0 as a headwind · 4 as a tailwind
6 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 44 companies compared. The sentences above are computed from all 44.Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「January 2024 Appointed as a standing Audit & Supervisory Board member of the Company (incumbent)」
The annual disclosure also confirms that Miura Makoto (三浦 誠) serves as a standing Audit & Supervisory Board member. - FY2024-Q3First statedAnnual report
「Audit & Supervisory Board member (standing) Miura Makoto (三浦 誠) January 2024 Appointed as an Audit & Supervisory Board member of the Company (incumbent) Audit & Supervisory Board member (standing) Odaka Yoshio (小高 芳夫) 29 January 2024 (Retirement due to resignation)」
As of 29 January 2024, Odaka Yoshio (小高 芳夫) resigned as a standing Audit & Supervisory Board member, and Miura Makoto (三浦 誠) became a standing Audit & Supervisory Board member.